Cardiovascular

Ocular involvement in Takayasu arteritis - A case series from a tertiary eye center in South India.

TL;DR

TAK is an important and underrecognized cause of ocular inflammation and ischemia in young patients; ocular involvement can precede systemic diagnosis, and early diagnosis and treatment results in a good visual outcome.

Key Findings

In this retrospective series of 13 TAK patients at a South Indian tertiary eye center, the disease predominantly affected young women.

  • Retrospective case series between 2016 and 2025.
  • 11 females and 2 males (female:male = 11:2).
  • Mean age was 31.92 ± 7.04 years.

Most patients first presented to an ophthalmologist rather than to another specialty.

  • Nine of 13 cases initially presented to an ophthalmologist.
  • The authors conclude that ocular involvement can precede systemic diagnosis.

Eye pain and diminution of vision were the most common presenting symptoms.

  • Eye pain was reported in eight cases.
  • Diminution of vision was reported in seven cases.
  • Two of the patients with diminished vision had sudden vision loss.

Ocular manifestations were varied, with ischemic changes and Takayasu retinopathy among the most frequent.

  • Ocular ischemia with retinal vessel spasm and constriction occurred in three cases.
  • Takayasu retinopathy occurred in three cases.
  • Central retinal artery occlusion occurred in one case.
  • Other presentations included optic disc pallor, dilated conjunctival and episcleral vessels, scleritis, hypertensive retinopathy, and atypical Tolosa Hunt syndrome.

Presumed ocular tuberculosis led to an incidental diagnosis of TAK in two cases.

  • TAK was identified during evaluation of presumed ocular tuberculosis in two patients.
  • This shows TAK can be diagnosed incidentally when ocular inflammation is attributed to another cause.

Imaging-based classification showed type I and type V as the most common TAK angiographic types.

  • Six cases had type I TAK.
  • Five cases had type V TAK.
  • One case each had type IV and type IIa TAK.

Treatment comprised systemic corticosteroids, conventional DMARDs, and tocilizumab, with good visual outcomes on early treatment.

  • Conventional DMARDs used were methotrexate and mycophenolate mofetil.
  • Tocilizumab was also used.
  • The authors report good visual outcome with early treatment in their series.

What This Means

This study looked back at 13 patients with Takayasu arteritis, a rare inflammatory disease of the large blood vessels, who were seen at an eye hospital in South India between 2016 and 2025. Most were young women, with an average age of about 32. Nine of the 13 first sought care from an eye doctor, most often because of eye pain or reduced vision, and two had sudden vision loss. The eye problems varied. They included reduced blood flow to the eye, damage to the retina's blood vessels, a blocked retinal artery, pale optic discs, scleritis, and an unusual presentation resembling Tolosa Hunt syndrome. In two patients, doctors first suspected eye tuberculosis, and Takayasu arteritis was found incidentally. Treatment included steroids, immune-suppressing drugs (methotrexate and mycophenolate mofetil), and tocilizumab. This research suggests that eye symptoms can be an early sign of Takayasu arteritis, sometimes before the whole-body disease is recognized. It also suggests that eye doctors may play a key role in spotting the condition, and that early diagnosis and treatment were associated with good vision outcomes. The study is small and retrospective, so these findings are descriptive and cannot show how often this occurs more widely.

Have a question about this study?

Citation

Babu K, Mooss V, Jois R. (2026). Ocular involvement in Takayasu arteritis - A case series from a tertiary eye center in South India.. Indian journal of ophthalmology. https://doi.org/10.4103/IJO.IJO_47_26